Cytori Therapeutics Inc Series S Warrant
CYTXZ
CYTXZ was delisted on the 23rd of July, 2019.
5 hedge funds and large institutions have $1K invested in Cytori Therapeutics Inc Series S Warrant in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
29% less funds holding
Funds holding: 7 → 5 (-2)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $271K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$269K |
| 2 |
Jefferies Group
New York
|
-$2K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$77 |
CYTXZ Hedge Fund Activity: Q2 2019 in Review
5 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Series S Warrant (CYTXZ) for Q2 2019, worth a combined $1K — down 100% from $273K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CYTXZ and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Anson Funds Management, exiting entirely with an estimated $269K sold.
- 5 institutional investors held Cytori Therapeutics Inc Series S Warrant (CYTXZ) as of Q2 2019, down from 7 in Q1 2019.
- Funds reported $1K of Cytori Therapeutics Inc Series S Warrant stock for Q2 2019, down 100% quarter-over-quarter.
- 0 funds opened new Cytori Therapeutics Inc Series S Warrant positions in Q2 2019 and 2 closed out, a net change of -2 holders.
- The largest Cytori Therapeutics Inc Series S Warrant seller in Q2 2019 was Anson Funds Management, an estimated $269K sold.
Based on aggregated 13F filings for Q2 2019.